Why not go with 3 trials in parallel,... one with BETonMACE with CHF instead of stroke,. another for CKD, another for Dementia.
We get a BP to pay the bills on all three and we get some money upfront, milestone payments, and royalties,... or we can sell the whole thing for a greater than $4 billion.